by Michael Morgenstern, MD | Sep 18, 2018 | Blog, Health care, medical marijuana
On June 25th, 2018, the U.S. Food & Drug Administration (FDA) approved Epidiolex (cannabidiol, CBD) for treatment of seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome, two forms of epilepsy. Epidiolex is the first plant-based drug derived from...
by Michael Morgenstern, MD | Nov 30, 2017 | Blog, medical marijuana
Patients often ask me what I think about Cannabidiol (CBD) purchased online. While these products may be less expensive than products purchased in a dispensary they may come at a cost such as being mislabeled, illegal or dangerous to consume. Online CBD oil are often...
Recent Comments